ATE141287T1 - Oligopeptide und ihre anwendung zu diagnose- und impfzwecken für aids und arc - Google Patents

Oligopeptide und ihre anwendung zu diagnose- und impfzwecken für aids und arc

Info

Publication number
ATE141287T1
ATE141287T1 AT88202248T AT88202248T ATE141287T1 AT E141287 T1 ATE141287 T1 AT E141287T1 AT 88202248 T AT88202248 T AT 88202248T AT 88202248 T AT88202248 T AT 88202248T AT E141287 T1 ATE141287 T1 AT E141287T1
Authority
AT
Austria
Prior art keywords
oligopeptides
arc
aids
diagnostic
sequence
Prior art date
Application number
AT88202248T
Other languages
English (en)
Inventor
Jaap Goudsmit
Robert Hans Meloen
Original Assignee
Stichting Centr Diergeneeskund
Az Univ Amsterdam
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Stichting Centr Diergeneeskund, Az Univ Amsterdam filed Critical Stichting Centr Diergeneeskund
Application granted granted Critical
Publication of ATE141287T1 publication Critical patent/ATE141287T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AT88202248T 1987-10-09 1988-10-07 Oligopeptide und ihre anwendung zu diagnose- und impfzwecken für aids und arc ATE141287T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NL8702403A NL8702403A (nl) 1987-10-09 1987-10-09 Oligopeptiden en gebruik daarvan voor diagnostische en vaccinatiedoeleinden voor aids en arc.

Publications (1)

Publication Number Publication Date
ATE141287T1 true ATE141287T1 (de) 1996-08-15

Family

ID=19850727

Family Applications (1)

Application Number Title Priority Date Filing Date
AT88202248T ATE141287T1 (de) 1987-10-09 1988-10-07 Oligopeptide und ihre anwendung zu diagnose- und impfzwecken für aids und arc

Country Status (8)

Country Link
EP (2) EP0311219B1 (de)
JP (1) JPH03501968A (de)
AT (1) ATE141287T1 (de)
CA (1) CA1340914C (de)
DE (1) DE3855471T2 (de)
ES (1) ES2094112T3 (de)
NL (1) NL8702403A (de)
WO (1) WO1989003391A1 (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0328390B1 (de) * 1988-02-10 1994-09-14 Immulogic Pharmaceutical Corporation Peptidbehandlung von hartnäckigen Infektionskrankheiten
CA1341285C (en) * 1988-02-12 2001-08-14 Chang Yi Wang Synthetic peptides for the detection of antibodies to hiv gp120 envelope protein for diagnosis of aids and pre-aids conditions and as vaccines
US5763160A (en) * 1988-02-12 1998-06-09 United Biomedical, Inc. Synthetic peptides and process of using same for the detection of antibodies to human immunodeficiency virus (HIV) gp120 envelope protein, diagnosis of AIDS and pre-AIDS conditions and as vaccines
US5562905A (en) * 1988-04-26 1996-10-08 E. I. Du Pont De Nemours And Company Human immunodeficiency virus (hiv) env-coded peptide capable of eliciting hiv-inhibiting antibodies in mammals
AU640619B2 (en) * 1988-10-03 1993-09-02 Repligen Corporation Hiv proteins and peptides useful in the diagnosis, prophylaxis or therapy of aids
SE9000333D0 (sv) * 1990-01-31 1990-01-31 Britta Wahren Monoklonal antikropp
EP0448095A1 (de) * 1990-03-21 1991-09-25 Wolf, Hans Joachim, Prof. Dr. Unterbereich des retroviralen ENV-Proteins, für diesen kodierende DNA-Sequenzen, sowie Stoffgemenge zur Verwendung in Diagnose, Verhinderung oder Therapie retroviraler Infektionen
AU8228791A (en) * 1990-06-15 1992-01-07 New York University Heterohybridomas producing human monoclonal antibodies to hiv-1
US5914109A (en) * 1990-06-15 1999-06-22 New York University Heterohybridomas producing human monoclonal antibodies to HIV-1
CA2047078A1 (en) * 1990-07-19 1992-01-20 Steven S. Bondy Cyclic hiv principal neutralizing determinant peptides
CA2047031A1 (en) * 1990-07-19 1992-01-20 Stephen Marburg Peptide-polysaccharide-protein conjugate vaccines
IL98845A0 (en) * 1990-07-19 1992-07-15 Merck & Co Inc Coconjugate vaccines comprising immunogenic protein,hiv related peptides,and anionic moieties,their preparation and pharmaceutical compositions containing them
IL99077A0 (en) * 1990-08-13 1992-07-15 Merck & Co Inc New embodiments of the hiv principal neutralizing determinant and pharmaceutical compositions containing them
US5627035A (en) * 1990-08-22 1997-05-06 Syntello Vaccine Development Ab Peptides that block human immunodeficiency virus and methods of use thereof
AU667290B2 (en) * 1990-08-22 1996-03-21 Tripep Ab Peptides that block human immunodeficiency virus infections and methods of use thereof
JPH06502539A (ja) * 1990-10-26 1994-03-24 ザ・パブリック・ヘルス・リサーチ・インスティチュート・オブ・ザ・シティ・オブ・ニューヨーク・インコーポレーテッド Ｈｉｖ−１　ｇｐ１２０のｖ３ループおよびｃｄ−４結合部位に特異的な中和ヒトモノクローナル抗体
EP0492920A1 (de) * 1990-12-24 1992-07-01 Merck & Co. Inc. Chimärer Influenza-HIV Impfstoff
US6139843A (en) * 1991-04-02 2000-10-31 Albert Einstein College Of Medicine Of Yeshiva University Peptide compositions for the treatment of HIV
JPH0570493A (ja) * 1991-05-31 1993-03-23 Chemo Sero Therapeut Res Inst ヒト免疫不全ウイルス（ｈｉｖ）関連免疫調製物
GB9318901D0 (en) * 1993-09-13 1993-10-27 Centre Nat Rech Scient Multiple branch peptide construction
WO2009008888A1 (en) * 2007-07-10 2009-01-15 Matthias Rath African swine virus polypeptides as vaccines and its therapeutic use thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US779431A (en) * 1903-06-02 1905-01-10 American Tobacco Co Cigarette-machine.
DE3588248T2 (de) * 1984-10-18 2004-07-01 Institut Pasteur LAV-Antigene und -Peptide
WO1987002775A1 (en) * 1985-10-24 1987-05-07 Southwest Foundation For Biomedical Research Synthetic peptides and use for diagnosis and vaccination for aids and arc

Also Published As

Publication number Publication date
EP0311219B1 (de) 1996-08-14
EP0311219A1 (de) 1989-04-12
JPH03501968A (ja) 1991-05-09
DE3855471T2 (de) 1996-12-19
CA1340914C (en) 2000-02-29
WO1989003391A1 (en) 1989-04-20
EP0389489A1 (de) 1990-10-03
DE3855471D1 (de) 1996-09-19
ES2094112T3 (es) 1997-01-16
NL8702403A (nl) 1989-05-01

Similar Documents

Publication Publication Date Title
ATE141287T1 (de) Oligopeptide und ihre anwendung zu diagnose- und impfzwecken für aids und arc
NO954440D0 (no) 2 pyridylmetylenpolyazamakrocyklo-fosfonsyrer, komplekser og derivater derav, for anvendelse som kontrastmidler
DE3855564D1 (de) Funktionalisierte Polyamin-Chelatbildner, ihre Komplexe und Verfahren zu ihrer Herstellung
NO954441L (no) Tricyklopolyazamakrocyklofosfonsyrer, komplekser og derivater derav for anvendelse som kontrastmidler
DK0784703T3 (da) Lamininkæder: Diagnostisk og terapeutisk anvendelse
HK184896A (en) Pharmaceutical composition comprising loratadine ibuprofen and pseudoephedrine
GR3030703T3 (en) Process for the production of biologically active protein (e.g. TGF)
NO176798C (no) Syntetisk peptid for påvisning av AIDS, fremgangsmåte for in vitro påvisning av antistoffer mot HIV og diagnose av AIDS, testsett for in vitro påvisning av antistoffer mot HIV og diagnose av AIDS, ARC og pre-AIDS tilstander
ATE78040T1 (de) Oligopeptide sowie zwischenprodukte und verfahren zu ihrer herstellung.
IL95742A0 (en) Recombinant polypeptides and peptides,nucleic acids coding for the same and use of these polypeptides and peptides in the diagnosis of tuberculosis
DE69518760T2 (de) Wachstumsdifferenzierungsfaktor-12
RU94041224A (ru) Пептиды с органозащитной активностью, фармацевтическая композиция на их основе и их применение в терапии
ATE84795T1 (de) Peptide mit einfluss auf die diurese und natriurese, verfahren zu ihrer herstellung, diese enthaltende mittel und ihre verwendung.
CA2103554A1 (en) Bicyclopolyazamacrocyclocarboxylic acid complexes, their conjugates, processes for their preparation, and use as contrast agents
CA2085465A1 (en) Thrombin inhibitors based on the amino acid sequence of hirudin
ES2057572T3 (es) Agentes de reconocimiento.
CA2241825A1 (en) New monofunctionalized edta, dtpa and ttha derivatives and their use in medical diagnosis and therapy
WO1996040763A3 (en) Peptides for hiv-1 detection
DK0732339T3 (da) Peptider fra HIV-gag-proteinet, fremstilling og anvendelse deraf
EP0317279A3 (de) Peptide für die Verwendung zur Reinigung von Faktor-VIII
DE3777359D1 (de) Aminosaeuresequenz des menschlichen alpha 2-plasmininhibitors und cdns sowie diese aminosaeuresequenz codierende genomische dns.
WO1990012807A3 (en) Purified, highly specific antibodies against gene products including retinoblastoma and method
AU542310B2 (en) Glicentin related purified peptide having 30 amino acids
ATE101393T1 (de) Phenanthridinderivate, verfahren zu ihrer herstellung und mittel zur ausfuehrung des verfahrens.
CA2201865A1 (en) Laminin chains: diagnostic and therapeutic use